Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

TARS Tarsus Pharmaceuticals Inc

53,31

4,53 (9,29%)

Zuletzt aktualisiert: 17:15:03

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Tarsus Pharmaceuticals Charts.

News Tarsus Pharmaceuticals Inc

Form 8-K - Current report
Freitag 17 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
Montag 13 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 19 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Tarsus Pharmaceuticals Inc News-Artikel

Interstar Mill S3 3G

TransCode Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen